<DOC>
	<DOCNO>NCT02082522</DOCNO>
	<brief_summary>Photodynamic therapy ( PDT ) combination drug , porfimer sodium ( Photofrin ) , activate light laser emit heat . This technique work allow medical doctor specifically target destroy abnormal cancer cell limit damage surround healthy tissue . The activation drug do light abnormal area use fiber optic device ( fine fiber like fish line permit light transmission ) insert flexible tube light call cholangioscope bile duct . The light activate porfimer sodium concentrate abnormal tissue , lead destruction . This research study evaluate efficacy safety PDT porfimer sodium administer Standard Medical Care ( SMC ) compare SMC alone overall survival time patient non-operable advanced cholangiocarcinoma , rare cancer bile duct . It involve 200 patient across North America Europe . Other country may participate need . Participation last least 18 month .</brief_summary>
	<brief_title>Efficacy Safety Study PDT Using Photofrin Unresectable Advanced Perihilar Cholangiocarcinoma ( OPUS )</brief_title>
	<detailed_description />
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Klatskin Tumor</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Dihematoporphyrin Ether</mesh_term>
	<mesh_term>Hematoporphyrin Derivative</mesh_term>
	<mesh_term>Trioxsalen</mesh_term>
	<criteria>Males female age 18 old Diagnosed radiologically biopsy cytology confirm inoperable perihilar cholangiocarcinoma Bismuth Tumor Stage III/IV Nonmenopausal nonsterile female subject childbearing potential must negative serum betaHCG use medically acceptable form birth control Able sign inform consent Diagnostic cholangiocarcinoma make 45 day prior randomization Cholangiocarcinoma extrahepatic metastasis concurrent nonsolid malignancy Presence history neoplasm ( treat last five year prior study entry ) carcinoma situ cervix basal carcinoma skin Previously receive photodynamic therapy cholangiocarcinoma Previously undergone surgical resection cholangiocarcinoma Previously undergone chemotherapy , brachytherapy , radiotherapy prior enter study Previously undergone metal stent insertion Porphyria hypersensitivity porphyrin ( constituent porfimer sodium ) , gemcitabine , cisplatin platinumcontaining compound Presence infection infection bile duct ( cholangitis ) Acute chronic medical psychological illness prevent endoscopy procedure Abnormal blood test result Severe impairment kidney liver function Decompensated cirrhosis Pregnant intend become pregnant , breastfeed intend breastfeed study Participated another drug study within 90 day one Unable unwilling complete followup evaluation require study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Cholangiocarcinoma</keyword>
	<keyword>Unresectable perihilar cholangiocarcinoma</keyword>
	<keyword>Klatskin tumor</keyword>
	<keyword>Photodynamic therapy</keyword>
	<keyword>Porfimer sodium</keyword>
	<keyword>Photofrin</keyword>
	<keyword>Gemcitabine</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Stents</keyword>
	<keyword>CCA</keyword>
	<keyword>PDT</keyword>
	<keyword>Bile duct cancer</keyword>
	<keyword>Bile duct tumor</keyword>
	<keyword>Bile duct adenocarcinoma</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>